
    
      Clinical Trial to estimate UACR determined albuminuria differences between treatment and
      non-treatment groups from basal intake to last study-related observation. Patients should
      suffer proteinuric Chronical Kidney Disease and recovered levels of seric 25(OH)D. Also, this
      clinical trial tries to determinate the effect of paricalcitol over several metabolic and
      inflammatory parameters on patients.
    
  